Advertisement

Thrombolysis, Angioplasty, and Stenting

  • Michael D. Dake
  • Suresh Vedantham

Abstract

As seen in the preceding chapters, modern improvements in the management of venous disease have originated through medical, rehabilitative and surgical innovations. From a radiological perspective, emergence of duplex ultrasound as a reliable method of evaluating the structure and function of the venous system has significantly enhanced our understanding of the pathophysiology of chronic venous insufficiency (CVI). Simultaneous advances in the interventional radiological management of arterial occlusive disease have created the theoretical foundation and technology supportive of a new approach to the prevention and treatment of venous disease: combined endovascular therapy using regional thrombolysis, balloon venoplasty and endovascular stent placement. While the results of long-term, controlled trials are not yet available, it has become increasingly clear that these percutaneous techniques have the potential to translate recent pathophysiological revelations into tangible clinical benefits.

Keywords

Iliac Vein Clot Lysis Chronic Venous Insufficiency Chronic Venous Insufficiency Left Common Iliac Vein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Goldhaber SZ. Venous thrombosis: prevention, treatment, and relationship to paradoxical embolism. Cardiol Clin 1994; 12:505–16PubMedGoogle Scholar
  2. 2.
    Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled clinical trial. Lancet 1960; 1:1309–12PubMedCrossRefGoogle Scholar
  3. 3.
    Strandness DE, Langlois Y, Cramer M et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250:1289–92PubMedCrossRefGoogle Scholar
  4. 4.
    O’Donnell TF, Browse NL, Burnand KG et al. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977; 22:483–8PubMedCrossRefGoogle Scholar
  5. 5.
    Van Ramshorst B, Van Bemmelen PS, Hoeneveld H,et al. Thrombus regression in deep venous thrombosis: quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86:414–19PubMedCrossRefGoogle Scholar
  6. 6.
    Markel A, Manzo RA, Bergelin RO et al. Valvular reflux after deep vein thrombosis: incidence and time of occurrence. J Vasc Surg 1992; 15:377–84PubMedCrossRefGoogle Scholar
  7. 7.
    Caps MT, Manzo RA, Bergelin RO et al. Venous valvular reflux in veins not involved at the time of acute deep vein thrombosis. J Vasc Surg 1995; 22:524–31PubMedCrossRefGoogle Scholar
  8. 8.
    Meissner MH, Manzo RA, Bergelin RO et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18:596–608PubMedCrossRefGoogle Scholar
  9. 9.
    Meissner MH, Caps MT, Bergelin RO et al. Propagation, rethrombosis, and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995; 22:558–67PubMedCrossRefGoogle Scholar
  10. 10.
    Sherry S. Thrombolytic therapy for deep vein thrombosis. Semin Intervent Radiol 1985; 4:331–7Google Scholar
  11. 11.
    Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993; 36:359–64PubMedGoogle Scholar
  12. 12.
    Killewich LA, Bedford GR, Beach KW et al. Spontaneous lysis of deep venous thrombi: rate and outcome. J Vasc Surg 1989; 9:89–97PubMedGoogle Scholar
  13. 13.
    Comerota AJ, Cohen G. Thrombolytic therapy in peripheral arterial occlusive disease: mechanisms of action and drugs available. Can J Surg 1993; 36:342–8PubMedGoogle Scholar
  14. 14.
    Graor RA, Young JR, Risius B et al. Comparison of cost-effectiveness of streptokinase and urokinase in the treatment of deep vein thrombosis. Ann Vasc Surg 1987; 1:524–8PubMedCrossRefGoogle Scholar
  15. 15.
    Goldhaber SZ, Meyerovitz MF, Green D et al. Randomized controlled trial of tissue plasminogen activator in proximal deep vein thrombosis. Am J Med 1990; 88:235–40PubMedCrossRefGoogle Scholar
  16. 16.
    Goldhaber SZ, Buring JE, Lipnick RJ et al. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep vein thrombosis. Am J Med 1984; 76:393–7PubMedCrossRefGoogle Scholar
  17. 17.
    Comerota AJ, Aldridge S. Thrombolytic therapy for acute deep vein thrombosis. Semin Vasc Surg 1992; 5:76–81Google Scholar
  18. 18.
    Theiss W, Wirtzfeld A, Fink U et al. The success rate of fibrinolytic therapy in fresh and old thrombosis of the iliac and femoral veins. Angiology 1983; 34:61–9PubMedCrossRefGoogle Scholar
  19. 19.
    Hill SL, Mortin D, Evans P. Massive venous thrombosis of the extremities. Am J Surg 1989; 158:131–5PubMedCrossRefGoogle Scholar
  20. 20.
    Arnesen H, Hoiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis. Acta Med Stand 1982; 211:65–8CrossRefGoogle Scholar
  21. 21.
    O’Meara JJ, McNutt RA, Evans AT et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. N Engl J Med 1994; 330:1864–9PubMedCrossRefGoogle Scholar
  22. 22.
    Becker GJ, Rabe FE, Richmond BD et al. Low-dose fibrinolytic therapy: results and new concepts. Radiology 1983; 148:663–70PubMedGoogle Scholar
  23. 23.
    Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Intervent Radiol 1991; 2:195–200CrossRefGoogle Scholar
  24. 24.
    Molina JE, Hunter DW, Yedlicka JW. Thrombolytic therapy for iliofemoral venouos thrombosis. Vasc Surg 1992; 26:630–7CrossRefGoogle Scholar
  25. 25.
    Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology 1994; 191:487–94PubMedGoogle Scholar
  26. 26.
    Bjarnason H, Kruse JR, Asinger DA et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Intervent Radiol 1997; 8:405–18CrossRefGoogle Scholar
  27. 27.
    Cragg AH. Lower extremity deep venous thrombolysis: a new approach to obtaining access. J Vasc Intervent Radiol 1996; 7:283–8CrossRefGoogle Scholar
  28. 28.
    Cope C, Baum RA, Duszak RA. Temporary use of a bird’s nest filter during iliocaval thrombolysis. Radiology 1996; 198:765–7PubMedGoogle Scholar
  29. 29.
    Ferris EJ, Lim WN, Smith PL et al. May-Thurner syndrome. Radiology 1983; 147:29–31PubMedGoogle Scholar
  30. 30.
    Masuda EM, Kistner RL. Long-term results of venous valve reconstruction: a four-to twenty-one-year follow-up. J Vasc Surg 1994; 19:391–403PubMedCrossRefGoogle Scholar
  31. 31.
    Weaver FA, Meacham PW, Adkins RB et al. Phlegmasia cerulea dolens: therapeutic considerations. South Med J 1988; 81:306–12PubMedCrossRefGoogle Scholar
  32. 32.
    Robinson DL, Teitelbaum GP. Phlegmasia cerulea dolens: treatment by pulse-spray and infusion thrombolysis. Am J Radiol 1993; 160:1288–90Google Scholar
  33. 33.
    Nazarian GK, Bjarnason H, Dietz CA et al. Iliofemoral venous stenoses: effectiveness of treatment with metallic endovascular stents. Radiology 1996; 200:193–9PubMedGoogle Scholar
  34. 34.
    Marache P, Asseman P, Jabinet JL et al. Percutaneous transluminal venous angioplasty in occlusive iliac vein thrombus resistant to thrombolysis. Am Heart J 1993; 125:362–6PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2000

Authors and Affiliations

  • Michael D. Dake
  • Suresh Vedantham

There are no affiliations available

Personalised recommendations